Pete, It does appear 2017 will go out with a wh
Post# of 72440
(Total Views: 226)
Posted On: 12/21/2017 9:24:41 AM
Pete,
It does appear 2017 will go out with a whimper for IPIX. I was boo'd and jeered for saying that this was a 2017 story a couple of years ago. I was off a little bit stock wise, but the bulk of four strong phase 2 trials were completed this year. We were destined for $0.70 as foretold in the prophecy but I didn't not think we would stay here so long.
I'm hopeful that Prurisol 2B will yield strong results next quarter and will give us quite a bit more leverage in negotiating a deal as we move farther into 2018. I will be holding what I have and adding as opportunities present themselves.
The IPIX team has been dealt a crappy hand of cards the past couple years but they have worked hard to mitigate it. It angers me when turds like Amateur, MXAMDUD and RDunn levy unfounded insults and accusations at the team. The IPIX C-suite has made all the right moves post-2015. Bringing on Dr. Bertolino and Jane Harness to help guide the advancement of the portfolio through clinicals and to partnership was paramount. They add huge credibility, experience and connections which compliment Dr. Menon's genius and Mr. Ehrlich's savvy business acumen. This team is working incredibly hard to bring life-changing drugs to patients and getting shareholders the return they deserve.
I have full faith and confidence in the team to deliver a deal in 2018 which will bring the stock to new highs.
Go IPIX!
It does appear 2017 will go out with a whimper for IPIX. I was boo'd and jeered for saying that this was a 2017 story a couple of years ago. I was off a little bit stock wise, but the bulk of four strong phase 2 trials were completed this year. We were destined for $0.70 as foretold in the prophecy but I didn't not think we would stay here so long.
I'm hopeful that Prurisol 2B will yield strong results next quarter and will give us quite a bit more leverage in negotiating a deal as we move farther into 2018. I will be holding what I have and adding as opportunities present themselves.
The IPIX team has been dealt a crappy hand of cards the past couple years but they have worked hard to mitigate it. It angers me when turds like Amateur, MXAMDUD and RDunn levy unfounded insults and accusations at the team. The IPIX C-suite has made all the right moves post-2015. Bringing on Dr. Bertolino and Jane Harness to help guide the advancement of the portfolio through clinicals and to partnership was paramount. They add huge credibility, experience and connections which compliment Dr. Menon's genius and Mr. Ehrlich's savvy business acumen. This team is working incredibly hard to bring life-changing drugs to patients and getting shareholders the return they deserve.
I have full faith and confidence in the team to deliver a deal in 2018 which will bring the stock to new highs.
Go IPIX!
(1)
(3)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
Scroll down for more posts ▼